Prelude Therapeutics Inc
PRLD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001678660
No open-market purchases or sales by Prelude Therapeutics Inc insiders were filed in the last 90 days; 75 institutions reported holding it in 13F filings for Q2 2026, worth $264.3M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Prelude Therapeutics Inc as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 55
- −5 vs. Q4 2022
- Shares held
- 31.5M
- +309.0K (+1.0%) vs. Q4 2022
- Total value
- $179.6M
- −$8.69M (−4.6%) vs. Q4 2022
- New holders
- 8
- 15 more added
- Sold out
- 13
- 15 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PRLD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 75 | $264.3M |
| Q1 2026 | 55 | $105.2M |
| Q4 2025 | 48 | $82.6M |
| Q3 2025 | 47 | $39.1M |
| Q2 2025 | 50 | $22.0M |
| Q1 2025 | 59 | $23.3M |
| Q4 2024 | 62 | $41.0M |
| Q3 2024 | 70 | $74.0M |
| Q2 2024 | 61 | $129.2M |
| Q1 2024 | 58 | $162.1M |
| Q4 2023 | 56 | $148.3M |
| Q3 2023 | 60 | $113.1M |
| Q2 2023 | 55 | $176.2M |
| Q1 2023 | 55 | $179.6M |
| Q4 2022 | 60 | $188.3M |
| Q3 2022 | 53 | $210.3M |
| Q2 2022 | 62 | $170.9M |
| Q1 2022 | 68 | $235.4M |
| Q4 2021 | 75 | $437.6M |
| Q3 2021 | 61 | $1.12B |
| Q2 2021 | 57 | $986.6M |
| Q1 2021 | 60 | $1.41B |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Prelude Therapeutics Inc; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 10,123,824 | $57.7M | 0.31% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 10,039,691 | $57.2M | 1.13% | 00.0% | Unchanged |
| FMR LLC | 4,546,678 | $25.9M | 0.00% | −42,914−0.9% | Reduced |
| UBS Asset Management Americas Inc | 2,273,894 | $13.0M | 0.01% | −62,050−2.7% | Reduced |
| Vanguard Group Inc | 916,014 | $5.22M | 0.00% | +16,700+1.9% | Added |
| Boxer Capital, LLC | 699,047 | $3.98M | 0.20% | +699,047 | New |
| Massachusetts Financial Services Co | 514,548 | $2.93M | 0.00% | −423−0.1% | Reduced |
| BlackRock Inc. | 423,028 | $2.41M | 0.00% | +29,475+7.5% | Added |
| Price T Rowe Associates Inc | 284,362 | $1.62M | 0.00% | −16,315−5.4% | Reduced |
| Geode Capital Management, LLC | 145,904 | $831.7K | 0.00% | +1,227+0.8% | Added |
| Morgan Stanley | 141,662 | $807.5K | 0.00% | +51,713+57.5% | Added |
| Renaissance Technologies LLC | 138,500 | $789.0K | 0.00% | +2,000+1.5% | Added |
| Millennium Management LLC | 136,519 | $778.0K | 0.00% | +86,783+174.5% | Added |
| Susquehanna International Group, LLP | 129,680 | $739.2K | 0.00% | +36,390+39.0% | Added |
| State of Wisconsin Investment Board | 90,200 | $514.1K | 0.00% | −10,200−10.2% | Reduced |
| Jacobs Levy Equity Management, Inc | 84,667 | $482.6K | 0.00% | +84,667 | New |
| Citigroup Inc | 70,767 | $403.4K | 0.00% | +10,695+17.8% | Added |
| Jane Street Group, LLC | 64,470 | $367.5K | 0.00% | +47,663+283.6% | Added |
| Charles Schwab Investment Management Inc | 62,851 | $358.3K | 0.00% | −870−1.4% | Reduced |
| Two Sigma Advisers, LP | 50,500 | $287.9K | 0.00% | −24,800−32.9% | Reduced |
| Goldman Sachs Group Inc | 49,496 | $282.1K | 0.00% | +33,732+214.0% | Added |
| Gsa Capital Partners LLP | 47,614 | $271.0K | 0.03% | −187−0.4% | Reduced |
| D. E. Shaw & Co., Inc. | 47,249 | $269.3K | 0.00% | −20,756−30.5% | Reduced |
| State Street Corp | 43,889 | $250.2K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 36,949 | $210.6K | 0.01% | 00.0% | Unchanged |
| Manufacturers Life Insurance Company, The | 34,298 | $195.5K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 30,377 | $173.1K | 0.00% | +17,250+131.4% | Added |
| 683 Capital Management, LLC | 28,631 | $163.2K | 0.01% | 00.0% | Unchanged |
| TD Asset Management Inc | 28,440 | $162.1K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 28,186 | $160.7K | 0.00% | −129,638−82.1% | Reduced |
| Man Group plc | – | $129.2K | 0.00% | – | – |
| Two Sigma Investments, LP | 22,455 | $128.0K | 0.00% | −29,443−56.7% | Reduced |
| HRT Financial LP | 22,175 | $126.0K | 0.00% | +22,175 | New |
| Northern Trust Corp | 21,167 | $120.7K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 16,198 | $92.3K | 0.00% | −1,425−8.1% | Reduced |
| Tower Research Capital LLC (TRC) | 13,352 | $76.0K | 0.00% | +9,820+278.0% | Added |
| Dimensional Fund Advisors LP | 12,759 | $72.7K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 11,201 | $64.0K | 0.01% | +11,201 | New |
| Two Sigma Securities, LLC | 10,922 | $62.3K | 0.01% | +10,922 | New |
| Barclays PLC | 10,322 | $58.8K | 0.00% | −80,502−88.6% | Reduced |
| Cubist Systematic Strategies, LLC | 8,778 | $50.0K | 0.00% | +8,778 | New |
| Denali Advisors LLC | 8,200 | $46.7K | 0.02% | 00.0% | Unchanged |
| Royal Bank of Canada | 5,258 | $30.0K | 0.00% | +959+22.3% | Added |
| Nisa Investment Advisors, LLC | 4,000 | $23.0K | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 2,130 | $12.0K | 0.00% | 00.0% | Unchanged |
| Point72 Middle East FZE | 1,680 | $9.58K | 0.00% | +1,680 | New |
| JPMorgan Chase & Co | 1,394 | $8.00K | 0.00% | +97+7.5% | Added |
| Point72 Asset Management, L.P. | 1,222 | $6.96K | 0.00% | +1,222 | New |
| UBS Group AG | 980 | $5.59K | 0.00% | −57−5.5% | Reduced |
| China Universal Asset Management Co., Ltd. | 649 | $3.70K | 0.00% | +279+75.4% | Added |
| Advisor Group Holdings, Inc. | 500 | $2.85K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 178 | $1.01K | 0.00% | −164−48.0% | Reduced |
| Bessemer Group Inc | 89 | $1.00K | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 104 | $1.00K | 0.00% | 00.0% | Unchanged |
| HighMark Wealth Management LLC | 50 | $285 | 0.00% | 00.0% | Unchanged |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −179,850−100.0% | Sold out |
| New York Life Investment Management LLC | 0 | $0 | 0.00% | −82,000−100.0% | Sold out |
| Caxton Associates LP | 0 | $0 | 0.00% | −65,453−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −28,879−100.0% | Sold out |
| Bleakley Financial Group, LLC | 0 | $0 | 0.00% | −22,325−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −18,232−100.0% | Sold out |
| Mirabella Financial Services LLP | 0 | $0 | 0.00% | −16,058−100.0% | Sold out |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −15,307−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −3,092−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −2,512−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −65−100.0% | Sold out |